HSCYX
Price
$37.60
Change
-$0.54 (-1.42%)
Updated
Jul 13 closing price
Net Assets
711.1M
VISGX
Price
$98.15
Change
-$1.40 (-1.41%)
Updated
Jul 13 closing price
Net Assets
47.01B
Interact to see
Advertisement

HSCYX vs VISGX

HSCYX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
HSCYX vs. VISGX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSCYX is a Buy and VISGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 47B vs. HSCYX (711M). VISGX pays higher dividends than HSCYX: VISGX (0.31) vs HSCYX (0.00). HSCYX was incepted earlier than VISGX: HSCYX (30 years) vs VISGX (28 years). HSCYX (0.99) is less costly to investors than VISGX (0.19). HSCYX is a more actively managed with annual turnover of: 71.00 vs. VISGX (24.00). VISGX has a lower initial minimum investment than HSCYX: VISGX (0) vs HSCYX (250000). HSCYX annual gain was more profitable for investors over the last year : 32.94 vs. VISGX (26.83). VISGX return over 5 years is better than : 27.48 vs. HSCYX (-1.22).
HSCYXVISGXHSCYX / VISGX
Total Expense Ratio0.990.19521%
Annual Report Gross Expense Ratio0.990.19521%
Fund Existence30 years28 years-
Gain YTD16.49417.34695%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets711M47B2%
Annual Yield % from dividends0.000.31-
Returns for 1 year32.9426.83123%
Returns for 3 years51.8951.09102%
Returns for 5 years-1.2227.48-4%
Returns for 10 years97.11180.4454%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCPX69.65N/A
N/A
Carillon ClariVest Capital Apprec A
WMMAX16.99N/A
N/A
TETON Westwood Mighty Mites A
SHPCX14.79N/A
N/A
Saratoga Health & Biotechnology C
ETCHX50.75N/A
N/A
Eventide Healthcare & Life Sciences C
PIIDX17.55N/A
N/A
Principal International Equity R-6